Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Locally Advanced Pancreatic Cancer Treated With ABLAtivE Stereotactic MRI-guided Adaptive Radiation Therapy (LAP-ABLATE)

NCT05585554 is registered in ClinicalTrials.gov with Viewray Inc. as lead sponsor.

NCT NCT05585554
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05585554 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Locally Advanced Pancreatic Cancer Treated With ABLAtivE Stereotactic MRI-guided Adaptive Radiation Therapy (LAP-ABLATE)
Lead sponsor
Viewray Inc.
Phase
Not applicable
Overall status
Not yet recruiting
Start date
July 31, 2023
Completion date
December 31, 2028
Enrollment
267 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer